219 related articles for article (PubMed ID: 24893782)
1. Epstein-Barr virus, the germinal centre and the development of Hodgkin's lymphoma.
Mohamed G; Vrzalikova K; Cader FZ; Vockerodt M; Nagy E; Flodr P; Yap LF; Diepstra A; Kluin PM; Rosati S; Murray P
J Gen Virol; 2014 Sep; 95(Pt 9):1861-1869. PubMed ID: 24893782
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma.
Leonard S; Wei W; Anderton J; Vockerodt M; Rowe M; Murray PG; Woodman CB
J Virol; 2011 Sep; 85(18):9568-77. PubMed ID: 21752916
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
Kurth J; Hansmann ML; Rajewsky K; Küppers R
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4730-5. PubMed ID: 12665622
[TBL] [Abstract][Full Text] [Related]
4. B cells under influence: transformation of B cells by Epstein-Barr virus.
Küppers R
Nat Rev Immunol; 2003 Oct; 3(10):801-12. PubMed ID: 14523386
[TBL] [Abstract][Full Text] [Related]
5. Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.
Minamitani T; Ma Y; Zhou H; Kida H; Tsai CY; Obana M; Okuzaki D; Fujio Y; Kumanogoh A; Zhao B; Kikutani H; Kieff E; Gewurz BE; Yasui T
Proc Natl Acad Sci U S A; 2017 May; 114(18):4751-4756. PubMed ID: 28351978
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus and the B cell: a secret romance.
Schuster VH; Müschen M
Trends Microbiol; 2003 Jun; 11(6):243-5. PubMed ID: 12823936
[TBL] [Abstract][Full Text] [Related]
7. Follicular dendritic cells display microvesicle-associated LMP1 in reactive germinal centers of EBV+ classic Hodgkin lymphoma.
Uccini S; Al-Jadiry MF; Pepe G; Pasquini A; Alsaadawi AR; Al-Hadad SA; Di Napoli A; Tripodo C; Ruco L
Virchows Arch; 2019 Aug; 475(2):175-180. PubMed ID: 31203443
[TBL] [Abstract][Full Text] [Related]
8. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
[TBL] [Abstract][Full Text] [Related]
9. Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression.
Liao Y; Yan J; Beri NR; Giulino-Roth L; Cesarman E; Gewurz BE
PLoS Pathog; 2024 Apr; 20(4):e1011939. PubMed ID: 38683861
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC
Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055
[TBL] [Abstract][Full Text] [Related]
12. Mouse model for acute Epstein-Barr virus infection.
Wirtz T; Weber T; Kracker S; Sommermann T; Rajewsky K; Yasuda T
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13821-13826. PubMed ID: 27856754
[TBL] [Abstract][Full Text] [Related]
13. The intersection of Epstein-Barr virus with the germinal center.
Roughan JE; Thorley-Lawson DA
J Virol; 2009 Apr; 83(8):3968-76. PubMed ID: 19193789
[TBL] [Abstract][Full Text] [Related]
14. Molecular detection of Epstein-Barr virus in different types of lymphoma.
Shaklawoon K; Altagazi N; Altorjman F; Alturki A; Eltaweel M; Alqawi O
Mol Biol Rep; 2020 Mar; 47(3):1803-1807. PubMed ID: 31993862
[TBL] [Abstract][Full Text] [Related]
15. Dynamic CD8 T-cell responses to tumor-associated Epstein-Barr virus antigens in patients with Epstein-Barr virus-negative Hodgkin's disease.
Kohrt H; Johannsen A; Hoppe R; Horning SJ; Rosenberg SA; Advani R; Lee PP
Oncol Res; 2009; 18(5-6):287-92. PubMed ID: 20225766
[TBL] [Abstract][Full Text] [Related]
16. Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma.
Araujo I; Foss HD; Hummel M; Anagnostopoulos I; Barbosa HS; Bittencourt A; Stein H
J Pathol; 1999 Feb; 187(3):326-30. PubMed ID: 10398087
[TBL] [Abstract][Full Text] [Related]
17. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency.
Kurth J; Spieker T; Wustrow J; Strickler GJ; Hansmann LM; Rajewsky K; Küppers R
Immunity; 2000 Oct; 13(4):485-95. PubMed ID: 11070167
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
[TBL] [Abstract][Full Text] [Related]
19. Association of Hodgkin's lymphoma with Epstein Barr virus infection.
Cickusić E; Mustedanagić-Mujanović J; Iljazović E; Karasalihović Z; Skaljić I
Bosn J Basic Med Sci; 2007 Feb; 7(1):58-65. PubMed ID: 17489771
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
